Cargando…

Antiplatelet combinations for prevention of atherothrombotic events

Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways. The present work reviews available evidence on antiplatelet therapy both for primary prevention and in the presence of established peripheral, cerebral, or cardiac ischemic disease. Due to the impo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollati, Mario, Gaita, Fiorenzo, Anselmino, Matteo
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037086/ https://www.ncbi.nlm.nih.gov/pubmed/21339910 http://dx.doi.org/10.2147/VHRM.S12271

Ejemplares similares

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Catheter Ablation of Atrial Fibrillation in Chronic Heart Failure: A Contemporary Review
por: Matta, Mario, et al.
Publicado: (2017)

Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases
por: Mohd Nor, Nurul Huda, et al.
Publicado: (2016)

Higher ventricular rate during atrial fibrillation relates to increased cerebral hypoperfusions and hypertensive events
por: Saglietto, Andrea, et al.
Publicado: (2019)

Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment
por: Anselmino, Matteo, et al.
Publicado: (2016)

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
por: Fintel, Dan J
Publicado: (2012)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Atrial fibrillation fundamentals: from physiopathology to transcatheter ablation
por: Gaita, Fiorenzo, et al.
Publicado: (2023)

Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
por: Jourdi, Georges, et al.
Publicado: (2022)

Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy
por: Balasubramaniam, Karthik, et al.
Publicado: (2012)

Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
por: Rosseto, Leandro Augusto, et al.
Publicado: (2015)

Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation
por: Scarsoglio, Stefania, et al.
Publicado: (2016)

A Computational Study on the Relation between Resting Heart Rate and Atrial Fibrillation Hemodynamics under Exercise
por: Anselmino, Matteo, et al.
Publicado: (2017)

Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis
por: Saglietto, Andrea, et al.
Publicado: (2019)

The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population
por: Falk, Erling, et al.
Publicado: (2011)

Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice
por: Ballatore, Andrea, et al.
Publicado: (2019)

Rate Control Management of Atrial Fibrillation: May a Mathematical Model Suggest an Ideal Heart Rate?
por: Anselmino, Matteo, et al.
Publicado: (2015)

Going “Green” in the Prevention and Management of Atherothrombotic Diseases: The Role of Dietary Polyphenols
por: Reis, Ana, et al.
Publicado: (2021)

Unexplored Roles of Erythrocytes in Atherothrombotic Stroke
por: Papadopoulos, Charalampos, et al.
Publicado: (2023)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Saglietto, Andrea, et al.
Publicado: (2021)

Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis
por: Puig, Núria, et al.
Publicado: (2023)

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events
por: Kario, Kazuomi
Publicado: (2016)

The Role of Biomarkers in Atherothrombotic Stroke—A Systematic Review
por: Andone, Sebastian, et al.
Publicado: (2021)

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
por: Mauriello, Alfredo, et al.
Publicado: (2023)

Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation
por: Faletti, Riccardo, et al.
Publicado: (2014)

Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Pouwels, Xavier G. L. V., et al.
Publicado: (2018)

Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
por: Theidel, Ulrike, et al.
Publicado: (2013)

Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
por: Patti, Giuseppe, et al.
Publicado: (2018)

α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2019)

Concentrated pineapple juice for visualisation of the oesophagus during magnetic resonance angiography before atrial fibrillation radiofrequency catheter ablation
por: Faletti, Riccardo, et al.
Publicado: (2018)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Nocella, Cristina, et al.
Publicado: (2021)

Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
por: Theidel, Ulrike, et al.
Publicado: (2013)

Cardiovascular Events in Patients with Atherothrombotic Disease: A Population-Based Longitudinal Study in Taiwan
por: Lee, Wen-Hsien, et al.
Publicado: (2014)

Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization
por: Liu, Xiaoling, et al.
Publicado: (2015)

Environmental noise exposure is associated with atherothrombotic risk
por: Koczorowski, Magali, et al.
Publicado: (2022)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6dakuqpjpl9p1tomgjrtn8s5c